CBD, or Cannabidiol, is beginning to make the transition from an obscure, cannabis related substance to a trusted medical option for a wide variety of health-related issues.
The majority of the CBD used for medicinal purposes originates from hemp, the least processed form of the Cannabis sativa plant. While THC is famous for being psychoactive, CBD does not have the same effects. People all over the world are enjoying the medical benefits CBD has to offer, without worrying about getting “high,” as it is possible to find medical strains that have little to no THC in the product. Lexaria’s DehydraTECH technology has the ability to improve taste, smell, bioabsorption and bioavailability of CBD edibles and products. Drastically improving the delivery time of pain relieving and anti-inflammatory CBD properties is a bonus for consumers and suppliers.
Embracing Non-Psychoactive CBD Components
Our bodies rely on CB1 and CB2 receptors to process cannabinoids such as CBD. We actually produce certain cannabinoids on our own within our body. While CB1 receptors are situated throughout the human anatomy, a large concentration is found within the brain. These receptors work with pain, mood, coordination, emotions, appetite, memories, thinking and much more. THC attaches to these receptors, causing psychoactive responses that commonly affect mood and getting the “munchies,” etc. CB2 receptors associated with CBD absorption are found in the immune system. These receptors work with pain and inflammation responses in the body. While it was initially believed that CBD directly interacts with CB2 receptors, science is finding that CBD may stimulate the body to use more of its’ own cannabinoids; promoting natural pain relief.
Inflammation Is A Common Immune Response For Many Ailments
The medical community is excited with CBD revelations as being beneficial for inflammation and pain relief. Individuals with chronic pain due to inflammation are finding relief without many of the negative side effects associated with traditional medications. The natural components of CBD preparations enable many people to use it in conjunction with other medications. Lexaria’s patented DehydraTECH technology allows the CBD to enter the bloodstream faster for increased absorption and faster results.
CBD is exhibiting some anti-cancer properties that have scientists very excited to learn more. The British Journal of Clinical Pharmacology published a review noting that CBD seems to block cancer cells from invading and spreading through an area. The ability to promote the death of cancer cells and suppressing their growth has the potential to revolutionize cancer treatment and success rates.
Explorations are being made into using CBD to treat other drug and alcohol withdrawal symptoms. In one recent study, smokers who utilized an inhaler with the compound CBD did not show additional nicotine cravings and ended up smoking fewer cigarettes. While research is still being conducted, the potential to help people kick their opioid use or smoking addiction and other symptoms associated with substance abuse including insomnia and anxiety are very promising.
Is Lexaria’s DehydraTECH Technology Perfect For Your Product?
Our world-class technology is suitable for numerous applications across a variety of industries. While CBD is one of our specialities, DehydraTECH technology can positively influence supplements, beverages, medicines and more! From mainstream markets to niche operations, delivering a reliable, absorbable product is what will keep your clients coming back for more.